Zydus receives NMPA approval in China for Venlafaxine extended-release capsules
This marks the first NMPA approval for Zydus in the Chinese market
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
SPDS to conduct Dissolution Science training programme for regulators in collaboration with DCGI,…
The training is scheduled for 12 November 2025 at CDSCO, Mumbai
Glenmark Specialty secures NMPA approval for RYALTRIS nasal spray
Commercialisation to be undertaken by Grand Pharmaceuticals under existing exclusive licensing agreement
Novo Nordisk India and Emcure Pharma announce partnership to launch Poviztra semaglutide injection…
Agreement covers distribution and marketing of Poviztra for weight management across expanded pharmacy networks and regions in…
Pristine Biologicals marks 10 years of supplying vaccine raw materials from New Zealand to India
The Dargaville-based unit of Indian Immunologicals Limited completes a decade of operations supporting vaccine production
Alembic Pharmaceuticals receives USFDA approval for Sumatriptan single-dose autoinjector
The product marks Alembic’s first drug–device combination to be approved in the United States
New data shows that targeted investment is reducing disruption in healthcare supply chains
DP World says targeted logistics investment is reducing disruption costs for healthcare companies
Global healthcare deal value increased in October 2025: GlobalData
GlobalData reports higher M&A and venture investment activity in the healthcare sector in October 2025.
Guaranteeing continuity of medicine supply through AI innovation
Whenever we speak of pharmaceutical innovation, we often focus on novel molecules or path-breaking therapies. The COVID 19…
Direct-to-Retail will increasingly complement traditional pharma distribution
Aqualab has crossed Rs 100 crore in just three years, what have been the key drivers behind this growth, and how does the brand…
India’s biopharma industry charts the road from biosimilars to innovation
Express Pharma hosted the maiden Biopharma Leadership Conclave 2025 and brought together industry leaders to discuss how India can…
AI and real-world evidence: The next frontier in clinical research
In the rapidly evolving world of clinical research, few developments hold as much promise—or provoke as much debate—as the…
Farmson unveils ₹300 Crore Acetic Anhydride unit in Vadodara
Farmson Basic Drugs unveiled its state-of-the-art Unit-VI manufacturing facility in Nandesari, Vadodara, Gujarat. This modern …
How HVAC is evolving from utility to critical quality enabler
Once viewed as a background utility, HVAC systems have become crucial to pharmaceutical manufacturing — enabling contamination…
Venus Remedies’ Methotrexate, Cefuroxime, and Irinotecan enters Vietnam
Venus Remedies has secured new marketing authorizations for Methotrexate, Cefuroxime, and Irinotecan in Vietnam. These regulatory…
Emcutix Biopharma unveils new AquaOat range in liposomal delivery of nano ceramide
Emcutix Biopharmaceuticals, a wholly-owned subsidiary of Emcure PharmaceuticalsL has announced the launch of the new AquaOat…
Lupin receives EIR from US FDA for its Pithampur unit-3 facility
Lupin announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration…
Bayer expands indication of Kerendia in India
Bayer announced that its innovative therapy Kerendia (finerenone) has received approval in India for the treatment of adult…
USFDA grants Orphan Drug Designation (ODD) to Zydus’ Desidustat for treatment of beta-thalassemia
Zydus, a leading, discovery-based, global pharmaceutical company announced that the USFDA has granted Orphan Drug Designation…
Senores Pharma forms new subsidiary to strengthen its US footprint
Senores Pharmaceuticals (SPI) acquired 51% stake in Zoraya Pharmaceuticals LLC, Delaware, USA through subscription of membership…